TCL Archive Lilly drug Alimta misses the target, but wins ODAC endorsement for lung cancer. FDA’s Pazdur tells ODAC that decision on Alimta requires clinical judgment. July 30, 2004
TCL Archive Greenwald Disagrees With WHT Report But Won’t Fight Decision; Will Ask For Limited Study, With Scope To Be Modified January 15, 1988
